First-Line Highly Effective Therapy Better for Pediatric MS
New research supports the use of highly effective therapies as first-line treatment in children with relapsing-remitting pediatric-onset multiple sclerosis.
Source: medscape.com
Interferon Beta News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Interferon Beta. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Interferon Beta Today - Breaking & Trending Today
Emerging Therapies Foretell New Era for Cutaneous Disorders
Analogous to the early 2000s when treatment options for psoriasis jumped, the same may be true now for treating cutaneous autoimmune disorders.
Source: medscape.com
A New Clue Into the Cause, Spread of Parkinson's Disease?
Damaged mitochondrial DNA initiates and spreads Parkinson's disease pathology, potentially opening new avenues for early diagnosis, researchers say.
Source: medscape.com
A Breakthrough in Interferon-based Therapies for Multiple Sclerosis
/PRNewswire/ -- Heligenics, Inc., a pioneering biotechnology company applying functional genomics to drug discovery, announced today that it has reshaped the...
Source: prnewswire.com
Atriva Therapeutics Announces Exclusive Letter Agreement for Reverse Takeover Transaction with Biocure Technology
Atriva Therapeutics and Canadian Biocure Technologies, Inc. entered into an exclusive letter agreement for a reverse takeover transaction. Upon successful completion of the transaction, the resulting entity will continue the business of Atriva Therapeutics. Shareholders of Atriva will receive not less than 75% of the securities of the resulting issuer, with the current shareholders of Biocure Technology holding the remainder. The transaction is subject to various terms and conditions, including
Source: yahoo.com